Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Immunotech Biopharm Ltd ( (HK:6978) ) is now available.
Immunotech Biopharm Ltd has announced a trading halt on its shares, effective from September 19, 2025, due to the pending release of an announcement regarding a rights issue. This development is significant as it involves inside information that could impact the company’s operations and stakeholder interests.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative immunotherapy products. The company operates in the healthcare industry with a market focus on cutting-edge biopharmaceutical advancements.
Average Trading Volume: 1,026,205
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.45B
Find detailed analytics on 6978 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “They Read Like a Cry for Help”, Starbucks Stock (NASDAQ:SBUX) Notches Up Despite Cup Note Concerns
- “The Merger of Marketing and Tech has Never Been Greater”: Home Depot Stock (NYSE:HD) Swings Up With Growing Marketing Plans
- Why Arista Networks Stock (ANET) Is Down Today and Why Morgan Stanley Says ‘Take the Plunge’